English | Español
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc to Release First-Quarter 2023 Financial Results on May 3, 2023
Patient Daily Report | Apr 7, 2023

Holmusk CEO on NeuroBlu Database: 'Our vision was to provide the gold standard for behavioral health real-world data'
Press release submission | Jul 3, 2022

Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis
Press release submission | Jul 1, 2022

More Surgical Care Cuts Take Effect Today, Harming Patients
Press release submission | Jul 1, 2022

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir

Press release submission | Jun 24, 2022

OM1 Launches a New Estimation Model for the Expanded Disability Status Score (EDSS) for Multiple Sclerosis Patients

Press release submission | Jun 23, 2022

CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma

Trending
+ Marketing
Patient Daily | Mar 14, 2025

Founder of Medfluence Advisors on healthcare marketing: 'The patient journey is more complex than ever'
+ Community
Patient Daily | Mar 14, 2025

Doctor on weather-related pressure headaches: This could happen 'if you have an underlying chronic sinus disease'
C.D. Marsden | Mar 14, 2025

Solidarity Health to Musk, RFK, Jr: ‘Enforce the CMS Hospital Price Transparency Rule’